BRTX BioRestorative Therapies, Inc.

Nasdaq biorestorative.com


$ 1.53 $ -0.09 (-5.45 %)    

Wednesday, 29-Oct-2025 19:45:02 EDT
QQQ $ 634.74 $ 2.85 (0.45 %)
DIA $ 476.09 $ -0.78 (-0.16 %)
SPY $ 686.84 $ 0.33 (0.05 %)
TLT $ 90.87 $ -0.93 (-1.01 %)
GLD $ 363.50 $ -1.38 (-0.38 %)
$ 1.56
$ 1.60
$ 1.47 x 200
$ 1.73 x 50
$ 1.49 - $ 1.69
$ 1.19 - $ 2.55
111,772
na
12.45M
$ 5,783.23
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-28-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 06-11-2024 03-31-2024 10-Q
7 03-29-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-11-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-27-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 03-30-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 05-17-2021 03-31-2021 10-Q
19 04-30-2021 12-31-2020 10-K
20 04-12-2021 06-30-2020 10-Q
21 04-12-2021 09-30-2020 10-Q
22 03-29-2021 03-31-2020 10-Q
23 03-18-2021 12-31-2019 10-K
24 11-13-2019 09-30-2019 10-Q
25 08-14-2019 06-30-2019 10-Q
26 05-15-2019 03-31-2019 10-Q
27 03-29-2019 12-31-2018 10-K
28 11-13-2018 09-30-2018 10-Q
29 08-14-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 04-02-2018 12-31-2017 10-K
32 11-14-2017 09-30-2017 10-Q
33 08-14-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 03-22-2017 12-31-2016 10-K
36 11-14-2016 09-30-2016 10-Q
37 08-15-2016 06-30-2016 10-Q
38 05-13-2016 03-31-2016 10-Q
39 03-30-2016 12-31-2015 10-K
40 11-23-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 biorestorative-secures-notice-of-allowance-for-japanese-patent-for-thermostem-platform

BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a regenerativ...

 biorestorative-therapies-reveals-1085m-registered-direct-offering-priced-above-market

MELVILLE, N.Y., Oct. 06, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or t...

 biorestorative-therapies-q2-eps-030-beats-037-estimate-sales-303000k-miss-340000k-estimate

BioRestorative Therapies (NASDAQ:BRTX) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate...

 biorestorative-therapies-announces-2m-stock-repurchase-program

BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a clinical st...

 biorestorative-to-present-stem-cell-trial-data-for-back-pain-at-global-conference

BioRestorative Therapies, Inc. ("BioRestorative," "BRTX" or the "Company") (NASDAQ:BRTX), a clinical-st...

 biorestorative-therapies-q1-eps-064-misses-033-estimate-sales-2500k-miss-38000k-estimate

BioRestorative Therapies (NASDAQ:BRTX) reported quarterly losses of $(0.64) per share which missed the analyst consensus estima...

 biorestorative-therapies-presents-preliminary-phase-2-brtx-100-data-at-isct-2025-annual-meeting

BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a clinical st...

 biorestorative-therapies-q4-2024-gaap-eps-020-beats-028-estimate-sales-43300k-miss-475000k-estimate

BioRestorative Therapies (NASDAQ:BRTX) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate...

 biorestorative-announces-fda-clearance-of-ind-for-phase-2-trial-of-brtx-100-in-chronic-cervical-discogenic-pain

– BRTX-100 is the first and only stem cell product candidate cleared to be evaluated in the cervical degenerative disc disease ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION